3 Potential Mid-Cap Biotech Buyout Targets In 2026
Source: SeekingAlpha
2025-12-03 18:22:57 ET
The biotech sector got off to an inauspicious start to December in trading on Monday. The iShares Biotechnology ETF ( IBB ) was off 2.14% yesterday while the State Street® SPDR® S&P® Biotech ETF ( XBI ) dropped 2.69% on Monday. This followed last week's big gains in a holiday trading week. The Dow was off .9%, the S&P 500 fell .53% and the NASDAQ pulled back .38%....
Read the full article on Seeking Alpha
For further details see:
3 Potential Mid-Cap Biotech Buyout Targets In 2026
Novartis AG
NASDAQ: NVS
NVS Trading
0.14% G/L:
$143.57 Last:
367,989 Volume:
$142.47 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
